Clinical application of the CASPAR criteria for psoriatic arthritis compared to other existing criteria

Clinical and Experimental Rheumatology

Volumn 28, Issue 3, 2010, Pages 304-310

  Congi, Laura ^a   Roussou, Euthalia ^b  

^a WHITTINGTON HOSPITAL   (United Kingdom)

^b KING GEORGE HOSPITAL   (United Kingdom)

Author keywords

CASPAR criteria; Classification criteria; Psoriatic arthritis

Indexed keywords

ADULT; ARTICLE; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; DELAYED DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE DURATION; FAMILY HISTORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; AGED; ANAMNESIS; CLASSIFICATION; MEDICAL AUDIT; MIDDLE AGED; PRACTICE GUIDELINE; PROFESSIONAL PRACTICE; REPRODUCIBILITY; RHEUMATOLOGY; STANDARD; UNITED KINGDOM;

ADULT; AGED; ARTHRITIS, PSORIATIC; FEMALE; GREAT BRITAIN; HUMANS; MALE; MEDICAL AUDIT; MEDICAL HISTORY TAKING; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; PROFESSIONAL PRACTICE; REPRODUCIBILITY OF RESULTS; RHEUMATOLOGY;

EID: 77956994481     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. WRIGHT V, MOLL JMH: Psoriatic arthritis. In: WRIGHT V, MOLL JMH (Eds.) Seronegative polyarthritis. Amsterdam: North Holland Publishing Co, 1976: 169-223.
2. MOLL JMH, WRIGHT V: Psoriatic arthritis. Semin Arthritis Rheum 1973; 3: 55-78.
3. WRIGHT V: Seronegative polyarthritis: a unified concept. Arthritis Rheum 1978; 21: 619-33.
4. BENNETT RM: Psoriatic arthritis. In: MCCARTY DJ (Ed.) Arthritis and Related Conditions. Philadelphia: Lea & Febiger, 1979: 645.
5. VASEY FB, ESPINOZA LR: Psoriatic arthritis. In: CALIN A (Ed.) Spondyloarthropathies. Orlando. Grune and Stratton, 1984: 151-85.
6. FOURNIÉ B, CROGNIER L, ARNAUD C et al.: Proposition des critères de classification du rheumatisme psoriasique. Etude préliminaire de 260 patients. Rev Rhum 1999; 66: 513-24.
7. DOUGADOS M, VAN DER LINDEN S, JUHLIN R et al.: The European Spondyloarthropathy Study Group preliminary criteria for the classification of spondyloarthropathy. Arthritis Rheum 1991; 34 1218-27.
8. MCGONAGLE D, CONAGHAN PG, EMERY: Psoriatic arthritis: a unified concept twenty years on. Arhritis Rheum 1999; 42: 1080-6.
9. GLADMAN DD, SHUCKETT R, RUSSELL ML, THORNE JC, SCHACHTER RK: Psoriatic arthritis: an analysis of 220 patients. Q J Med 1987; 238: 127-41.
10. TAYLOR W, GLADMAN D, HELLIWELL P et al.: Classification criteria for psoriatic arthritis: Development of new criteria from a large international study. Arthritis Rheum 2006; 54: 2665-73.
11. HELLIWELL PS, GRAPPA GROUP (Group for Research and Assessment of Psoriasis and Psoriatic Arthritis), Stockholm, May/June 2006. J Rheumatol 2007; 34: 214-9.
12. CHANDRAN V, SCHENTAG CT, GLADMAN DD: Sensitivity of the Classification of Psoriatic Arthritis Criteria in Early Psoriatic Arthritis. Arthritis Rheum 2007; 57: 1560-3.
13. GLADMAN DD, SHUCKETT R, RUSSELL ML, THORNE JC, SCHACHTER RK: Psoriatic arthritis (PsA): an analysis of 220 patients. Q J Med 1987; 62: 127-41.
14. SILMAN A: Psoriatic arthritis. In: SILMAN A, HOCHBERG MC (Eds.) Epidemiology of the Rheumatic Diseases Oxford. Oxford University Press, 2001: 85-99.
15. HELLIWELL E, TAYLOR WJ: Classification and diagnostic criteria for psoriatic arthritis. Ann Rheum Dis 2005; 64 (Suppl. II): ii3-8.
16. GLADMAN DD: Psoriatic arthritis. Baillieres Clin Rheumatol 1995: 9: 319-29.
17. GORTER S: Psoriatic arthritis: performance of rheumatologists in daily practice. Ann Rheum Dis 2002; 61: 219-24.
18. ARNETT FC, EDWORTHY SM, BLOCH DA et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
19. TAYLOR WJ, FELLOW DE, HELLIWELL PS: Case definition of psoriatic arthritis. Lancet 2000; 356: 2095; author reply 2096.
20. HELLIWELL P: New criteria for classifying PsA in clinical research. Rheumatology in Practice 2007; 5: 13-5.
21. BROCKBANK JE, STEIN M, SCHENTAG CT, GLADMAN DD: Dactylitis in psoriatic arthritis: a marker for disease severity? Ann Rheum Dis 2005; 64: 188-90.
22. CLEGG DO, REDA DJ, MEJIAS E et al.: Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study. Arthritis Rheum 1996; 39: 2013-20.
23. SALVARANI C, CANTINI F, OLIVIERI I et al.: Efficacy of infliximab in resistance psoriatic arthritis. Arthritis Rheum 203; 49: 541-5.
24. KALTWASSER JP, NASH P, GLADMAN D et al.: Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial. Arthritis Rheum 2004; 50: 1939-50.
25. ANTONI CE, KANAUGH A, KIRKHAM B et al.: Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT). Arthritis Rheum Dis 2005; 52: 1227-36.
26. ANTONI CE, KRUEGER GG, DE VLAM K et al.: Infliximab improves signs and symptoms of psoriatic arthritis: results from the IMPACT 2 trial. Ann Rheum Dis 2005; 64: 1150-7.
27. HELLIWELL PS, FIRTH J, IBRAHIM GH, MELSOM RD, SHAH I, TURNER DE: Development of an assessment tool for dactylitis in patients with psoriatic arthritis. J Rheumatol 2005; 32: 1745-50.
28. KAVANAUGH A, RITCHLlN C, BOEHNCKE WH: Quality indicators in psoriatic arthritis. Clin Exp Rheumatol 2007; 25 (Suppl. 47): 98-101.